Edarbi (Azilsartan Kamedoxomil) - Published Studies

Edarbi Related Published Studies

Well-designed clinical trials related to Edarbi (Azilsartan)

Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study. [2012]

Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. [2011]

Well-designed clinical trials possibly related to Edarbi (Azilsartan)

Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation. [2015]

Other research related to Edarbi (Azilsartan)

Efficacy of azilsartan medoxomil with chlorthalidone in hypertension. [2014]

Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertension. [2014]

Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertension. [2014]

Rationale, study design, and implementation of the ACS1 study: effect of azilsartan on circadian and sleep blood pressure as compared with amlodipine. [2014]

Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive. [2013]

Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study. [2012]

Azilsartan: a newly approved angiotensin II receptor blocker. [2011]

Other possibly related research studies

An evaluation of the latest evidence relating to renin-angiotensin system inhibitors. [2013]